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The genes encoding C2, C4, and Factor B of human complement map between 
the B locus of class I products and the D locus of class II products in the MHC 
on chromosome 6 (1).  These proteins,  together with C3, are the precursors of 
the C3 convertases of the classical and  the alternative pathway of complement 
(2,  3).  Formation  of C3  convertase  is  the  critical  event  in  both  pathways:  it 
eventuates  in  opsonization  of particles,  release  of inflammatory  peptides,  C5 
convertase formation, and cell iysis. The two enzymes, which have the structural 
formulas C4b,2a and C3b,Bb ~ are serine proteases (2). The catalytic sites reside 
in  the atypically large C2a (80 kd) and  Bb (63 kd) subunits, whose N-terminal 
amino acid sequences show no homology with  those of other serine  proteases 
(4-6).  These  C3  convertases  are  also  unusual  in  terms  of their  kinetic  and 
thermodynamic  instability.  The  catalytic subunits,  once dissociated from  their 
cofactors, cannot rebind to form an active enzyme. 
We have recently shown that subunit Bb displays a two-domain structure that 
is  unusual  among  serine  proteases  (7).  We now wish  to  report  that  C2a also 
displays a  two-domain  structure,  that  the  zymogens C2  and  Factor  B  possess 
three  domains,  and  that  the  morphologies  of the  enzyme  complexes,  their 
analogous subunits and precursors are very similar. 
Materials and Methods 
Generation of Fluid Phase C4b,2a  or C3b,  Bb.  C2,  C3,  C3b,  C4,  C4b,  Factor B,  Cls...z, 
Factor D were isolated as described (2, 8, 9). 80 #g C4, 40 and #g C2, and  1.2 #g Cls 
(molar ratios  100:100:3) or 80 #g C3b, 40 #g Factor B, and 0.5 #g Factor D (molar ratios 
100:100:5) were incubated in the presence of 0.5 mM MgCl2 and 0.15 mM CaCl2 at 37 °C 
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in a total volume of 277 #1 VBS. At timed intervals, three aliquots were withdrawn:  1) 5 
el was diluted into ice cold volatile buffer (0.1  M ammonium acetate, 0.05 M ammonium 
bicarbonate, 0.1  mM EDTA, pH 7.2) and immediately mounted for electron microscopy. 
2)  10 el was transferred to 90 el of ice cold VBE containing C3 for determination of C3 
convertase activity (10).  3)  15 tA was subjected to SDS polyacrylamide gel (8%) electro- 
phoresis (11). 
Electron Microscopy.  Samples of 5 ug/mi in the above volatile buffer were adsorbed to 
thin  carbon films and negatively stained with  1%  uranyl formate (Eastman,  Rochester, 
NY) using the pleated sheet technique (12).  Images similar in character but inferior in 
quality were obtained when nonvolatile buffers used. Pleated regions of the grid surface 
were photographed at a primary magnification of 64,000 in a Hitachi  12 A transmission 
electron microscope operating at 75 kV with a 200-/~m C~ aperture and a 50-t~m objective 
aperture. Magnification calibration of the instrument was performed by standard methods 
(13). 
Results 
The respective reaction mixtures for enzyme formation were prepared at 0°C, 
transferred  to  37°C,  and  aliquots  were  then  removed  at  timed  intervals  for 
immediate  assay  of C3  convertase  activity,  processing  for electron  microscopy, 
and SDS polyacrylamide gel electrophoresis.  Both C3 convertases were formed 
very rapidly and although  some uncleaved C2 and Factor B remained after 0.5 
FIGURE I.  Electron micrographs of the human alternative pathway C3 convertase, C3b,Bb 
and precursors. C3b displays  a highly irregular substructure (arrows). Factor B appears globular 
with the suggestion (arrow) of a tl~ee domain substructure.  Bb possesses  two discrete globular 
domains, only one of which makes contact with C3b within the enzyme complex. All images 
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min, further incubation did not result in increased C3 convertase activity due to 
the rapid decay-dissociation of both enzymes. Field view electron micrographs 
(not shown) also showed that C3b,Bb complexes and C4b,2a  complexes were 
pronounced at the early time points and that they gradually diminished until no 
complexes were seen after 10 rain. 
Comparison of the electron micrographs depicted in Figs.  1 and 2 shows C3b 
(~176  kd) and C4b (,~185  kd) have a  similar globular appearance, consistent 
with hydrodynamic evidence (2,  14) and to have an irregular, apparently multi- 
ple-domain substructure. This is especially pronounced in C3b images (arrows, 
Fig.  1).  Both molecules would be contained within a parallelepiped measuring 
approximately 125  +~ ×  75 A x  65 A. The most conspicuous projection in both 
cases  (arrows)  is  that of a  larger  head  region  connected to a  smaller tail-like 
structure. Micrographs of the precursors C3 and C4 appeared indistinguishable 
from those of C3b and C4b. 
The catalytic site-bearing subunits Bb (Fig.  1) and C2a (Fig.  2) appear very 
similar,  both  consisting of two  globular domains connected by  a  thin  linker 
segment -~10  A  long corresponding to  ~5  kd in molecular weight. Although 
both domains of Bb appear nearly identical, one domain of C2a often appears 
larger. Measurement of center-to-center distances gave 50 __+ 2 A (+ SD) for Bb 
FIGURE 2.  Electron micrographs of human classical pathway C3 convertase, C4b,2a and 
precursors. C4b appears very similar  to C3b (Fig. 1); both proteins  share a distinctive  structure 
noted by arrows. C2 is globular with the suggestion of domain substructure (arrow). C2a 
possesses two discrete globular domains  of unequal size. Only  one domain  attaches to C4b in 
the bimolecular  complex C4b,2a. All images  magnified  x 480,000. SMITH  ET  At,.  BRIEF  DEFINITIVE  REPORT  327 
and 55  +  2  A  (+- SD) for C2a.  The diameter of each Bb domain is therefore 
estimated to be 42 A and using a ~¢ of 0.72 (15), the estimated molecular weight 
of one domain is  -~28  kd.  Assuming the smaller domain of C2a to be of the 
same size as the domains of Bb, the larger domain of C2a has a diameter of 47 
A,  which  corresponds  to  "--39  kd.  The  catalytic subunit  of both  enzymes is 
oriented approximately orthogonal to the long axis of the cofactor, and bound 
through only one of the two domains. 
The zymogens Factor B  (Fig.  1) and C2  (Fig.  2) both appear globular with 
diameters of 80  +  8  ,~  (+ SD) and 85  _+  8  A  (+ SD),  respectively. However, 
pronounced substructure is evident. Bipartite  images of Factor B and C2  are 
consistent with their cleavage pattern by proteases (4,  6,  14,  15):  two regions, 
one approximately twice as large as the other. Often, three-lobed structures are 
seen, each lobe measuring ~40 A  in diameter. Consistent with these images is 
the similarity in molecular weight of the activation fragments Ba and C2b (2, 3) 
and of the estimated molecular weights of the domains of Bb and C2a. 
Discussion 
The apparent presence of multiple domains in C3b and C4b is consistent with 
the fact that both cofactors possess  multiple protein binding sites.  These sites 
include  the  Bb  or  C2a  binding  site,  the  metastable  binding  site  or  reactive 
thioester (16-18)  through which these molecules covalently attach to cell sur- 
faces, sites for regulatory proteins which either abrogate or enhance the activity 
of the C3 convertases (2), and sites specific for cell surface receptors (19). 
It  is  probable  that  C3  and  C4  arose  by  gene duplication  because:  (a)  the 
anaphylatoxins  C3a  and  C4a,  which  are  derived  from  the  o~-chain of these 
proteins, show considerable amino acid sequence homology (20); (b) the regions 
surrounding the reactive thioester also indicate homology (2 I); (c) both proteins 
are  synthesized  as  single  chain  polypeptides  and  subsequently  processed  to 
multiple chain structures (3);  and (d) they are functional analogues. The mor- 
phological  similarity between  C3b  and  C4b  deduced by electron microscopy 
further  suggests  a  common evolutionary origin,  even  though  C4b  is  15  kd 
greater in molecular mass than C3b, possesses a  three-chain rather than a  two- 
chain structure and the genes of human C3 and C4 map to different chromosomes 
(22, 23). 
We have shown that subunits Bb and C2a both consist of two discrete globular 
domains,  although  previous  attempts  to  cleave these  proteins  with  proteases 
failed to reveal the two-domain substructures (4,  6,  15).  The finding that C2a 
and C2a and Bb bind to their cofactors through only one domain indicates that 
this domain is the binding domain and suggests but does not prove that the other 
may be the catalytic domain. In the case of C2a, the smaller of the two domains 
(-28 kd), which is comparable in size to the Bb domains, may be postulated to 
contain the enzymatic site. Such intramolecular arrangement would localize the 
catalytic site to a domain similar in size and shape to other serine proteases (24). 
If the freely projecting domain of the catalytic subunits in both C3 convertases 
contains the catalytic site, then this domain would represent the COOH-terminal 
half of C2a and Bb, because the reactive serine residue of serine proteases resides 
in that portion of the molecule (5).  That both enzymes are serine proteases has 328  SMITH  ET  AL.  BRIEF  DEFINITIVE  REPORT 
been  deduced  from  their  diisopropyl-fluorophosphate  (DFP)  inhibitability  (2) 
and  from  sequence  analyses  of Bb  (4,  5).  Although  it  is  clear  that  in  both 
proteases the catalytic site resides in a discrete 28-kd domain and that cofactor 
attachment occurs through one domain only, it is not known whether both sites 
reside in the same domain. Crystal structure comparisons (24, 25) of chymotryp- 
sinogen  and  a-chymotrypsin  have  elucidated  in  detail  the  critical  role  of the 
conserved  NH2-terminal  residues  in  the  canonical  refolding  events.  Because 
these amino  acid residues are  not present  in  Bb (4,  5),  the activation  process 
must be different from that of other serine proteases. 
The suggestion that C2 arose from Factor B by gene duplication is consistent 
with their functional and physicochemical similarities,  their structural  similarity 
deduced  by electron  microscopy,  and  the  fact  that  both  genes  map  in  close 
proximity  to  each  other  (1).  However,  the  multiple  domain  substructures  of 
these proteins suggest a  more intricate evolutionary process that remains to be 
defined. 
Summary 
We have reported  a  transmission  electron  microscopic study of the  two C3 
convertases  of human  complement  and  their  precursors.  The  corresponding 
proteins  and  complexes  of the  classical  and  alternative  pathway  appear  very 
similar.  Cofactors  C3b  and  C4b  are  nearly  indistinguishable  and  display  a 
characteristic  but highly irregular  substructure.  C2 and  Factor B are globular 
with diameters of 85  _+ 8  A  and  80  +  8  A  and both consist of three  discrete 
globular domains each ~40 A in diameter. Bb and C2a each contain two domains 
connected by. a  short linker  segment.  Both domains of Bb and one domain  of 
C2a are  42  A  in diameter  (28 kd), while the second domain  of C2 is  47 A  in 
diameter  (39  kd).  Attachment  of the  enzymatic  subunits  to  cofactors  occurs 
through one domain only. 
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